Showing results (611-620 of 2,225) with videos related to
Sort By:
Pageof 223
Handbook of Experimental Pharmacology|October 21, 2022
Pharmacometabolomics of Asthma as a Road Map to Precision MedicineRachel S Kelly, Margaret F Cote, Sofina Begum, et al.Handbook of Experimental Pharmacology|November 1, 2022
Natural Products Drug Discovery: On Silica or In-Silico?Hye Kyong Kim, Young Hae Choi, Robert VerpoorteHandbook of Experimental Pharmacology|October 29, 2022
Quantitative NMR Methods in MetabolomicsG A Nagana Gowda, Daniel RafteryHandbook of Experimental Pharmacology|August 30, 2022
Fluoride Transport and Inhibition Across CLC TransportersSomayeh Asgharpour, L América Chi, Marc Spehr, et al.Handbook of Experimental Pharmacology|April 13, 2011
Dual acting and pan-PPAR activators as potential anti-diabetic therapiesMonique Heald, Michael A CawthorneHandbook of Experimental Pharmacology|April 13, 2011
GLP-1 agonists and dipeptidyl-peptidase IV inhibitorsBaptist GallwitzHandbook of Experimental Pharmacology|April 13, 2011
SGLT inhibitors as new therapeutic tools in the treatment of diabetesRolf K H Kinne, Francisco CastanedaHandbook of Experimental Pharmacology|April 13, 2011
Inhibition of ganglioside biosynthesis as a novel therapeutic approach in insulin resistanceJin-Ichi InokuchiHandbook of Experimental Pharmacology|June 23, 2011
Phosphodiesterase inhibitors: history of pharmacologyChristian Schudt, Armin Hatzelmann, Rolf Beume, et al.Handbook of Experimental Pharmacology|June 23, 2011
The GAF-tandem domain of phosphodiesterase 5 as a potential drug targetJoachim E Schultz, Torsten Dunkern, Elvira Gawlitta-Gorka, et al.Pageof 223